These resources have been put together by the NHS England Pharmacy Communications team. They are designed for professionals to use with patients to support introduction of biosimilar adalimumab.
Attachments
- Adalimumab Patient FAQ Final - updated 19 September · PDF · 274 KB
- Adalimumab Template Patient Letter - Final - 9 August · Word · 32 KB
- Adalimumab-Article-for-Patient-Newsletters-Final-Oct-2018[1] · Word · 100 KB